Evidence map›Paper›PMID 42506869›Full record

ArticleTomography (Ann Arbor, Mich.)2026

Clinical Robustness of FDG-PET/CT Quantitative Metrics Post-Harmonization in a Multicenter, Cross-Scanner Setting.

Ayako Hino, Yoshinobu Ishiwata, Akira Kakiuchi, Tomohiro Numata, Hiroyuki Kamide, Hiroaki Kurihara, Zenjiro Sekikawa, Daisuke Utsunomiya

Abstract readMulticenter Study
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ayako HinoDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ward, Yokohama 2418515, Japan.ORCID 0000-0002-3430-7567
Yoshinobu IshiwataDepartment of Nuclear Medicine, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-Ward, Yokohama 2360004, Japan.ORCID 0000-0002-9425-0582
Akira KakiuchiDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ward, Yokohama 2418515, Japan.
Tomohiro NumataDepartment of Diagnostic Radiology, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-Ward, Yokohama 2320024, Japan.
Hiroyuki KamideDepartment of Diagnostic Radiology, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-Ward, Yokohama 2320024, Japan.
Hiroaki KuriharaDepartment of Diagnostic and Interventional Radiology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ward, Yokohama 2418515, Japan.
Zenjiro SekikawaDepartment of Diagnostic Radiology, Yokohama City University Medical Center, 4-57 Urafunecho, Minami-Ward, Yokohama 2320024, Japan.ORCID 0000-0003-1291-5657
Daisuke UtsunomiyaDepartment of Diagnostic Radiology, Yokohama City University Hospital, 3-9 Fukuura, Kanazawa-Ward, Yokohama 2360004, Japan.ORCID 0000-0002-1723-1724

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fluorodeoxyglucose F18Head and Neck NeoplasmsMelanomaPositron Emission Tomography Computed TomographyHumansPhantoms, ImagingRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticalsbiomarker robustnessclinical PET imaginginter-scanner harmonizationMTVmulticenterSUVmaxSUVpeak

Identifiers

PMID42506869
PMCPMC13417090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.